BIOA vs KIM · rev $9.0M vs P/E 27, rev $1.11B
BioAge Labs, Inc (BIOA) versus Kimco Realty Corporation (KIM) — a side-by-side from cached financials, not a winner call.
BioAge Labs, Inc (BIOA) is a drug manufacturers - specialty & generic company listed on US.
Kimco Realty Corporation (KIM) is a reit - retail company listed on US.
Latest reported BIOA revenue for 2025-12-31 was $9.0M. Net income was -$80.6M. BIOA currently screens at market cap $697.9M.
Latest reported KIM revenue for 2026-06-30 was $1.11B. Net income was $318.2M. Revenue was up 98.7% from 2026-03-31 to 2026-06-30. KIM currently screens at market cap $16.03B and trailing P/E 27.3.
BIOA currently screens at market cap $697.9M. KIM currently screens at market cap $16.03B and trailing P/E 27.3.
Not investment advice. Open the BIOA and KIM stock pages for the full models.
Not investment advice.